1. Dal Canto, E, Ceriello, A, Rydén, L, et al Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol 2019; 26 (2_Suppl): 25–32.
Google Scholar | SAGE Journals | ISI2. Rydén, L, Ferrannini, G, Mellbin, L. Risk factor reduction in type 2 diabetes demands a multifactorial approach. Eur J Prev Cardiol 2019; 26 (2_Suppl): 81–89.
Google Scholar | SAGE Journals3. Prattichizzo, F, La Sala, L, Rydén, L, et al. Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases. Eur J Prev Cardiol 2019; 26 (2_Suppl): 73–80.
Google Scholar | SAGE Journals | ISI4. Pulipati, VP, Ravi, V, Pulipati, P . Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Eur J Prev Cardiol 2020; 27: 1922–1930.
Google Scholar5. Di Benedetto, L, Michels, G, Luben, R, et al. Individual and combined impact of lifestyle factors on atrial fibrillation in apparently healthy men and women: the EPIC-Norfolk prospective population study. Eur J Prev Cardiol 2018; 25: 1374–1383.
Google Scholar | SAGE Journals | ISI6. Lee, Y, Cha, SJ, Park, JH, et al. Association between insulin resistance and risk of atrial fibrillation in non-diabetics. Eur J Prev Cardiol 2020; 27: 1934–1941.
Google Scholar7. Cortesi, PA, Fornari, C, Madotto, F, et al. Trends in cardiovascular diseases burden and vascular risk factors in Italy: the Global Burden of Disease Study 1990 2017. Eur J Prev Cardiol. Epub ahead of print 24 August 2020. DOI: 10.1177/2047487320949414
Google Scholar8. Byambasukh, O, Eisenga, MF, Gansevoort, RT, et al. Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: the PREVEND cohort study. Eur J Prev Cardiol 2019; 26: 905–916.
Google Scholar | SAGE Journals | ISI9. Mohammadi, H, Ohm, J, Discacciati, A, et al. Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction. Eur J Prev Cardiol 2020; 27: 1944–1952.
Google Scholar10. Garcia-Rubira, JC, Cano-Garcia, FJ, Bullon, B, et al. Body fat and metabolic age as indicators of inflammation and cardiovascular risk. Eur J Prev Cardiol 2018; 25: 233–234.
Google Scholar | SAGE Journals | ISI11. Schrover, IM, van der Graaf, Y, Spiering, W, et al.; SMART study group. The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease. Eur J Prev Cardiol 2018; 25: 1548–1557.
Google Scholar | SAGE Journals | ISI12. Alvarez-Alvarez, I, de Rojas, JP, Fernandez-Montero, A, et al. Strong inverse associations of Mediterranean diet, physical activity and their combination with cardiovascular disease: the Seguimiento Universidad de Navarra (SUN) cohort. Eur J Prev Cardiol 2018; 25: 1186–1197.
Google Scholar | SAGE Journals | ISI13. Yi, SY, Steffen, LM, Terry, JG, et al. Added sugar intake is associated with pericardial adipose tissue volume. Eur J Prev Cardiol 2020; 27: 2016–2023.
Google Scholar14. Kwok, CS, Gulati, M, Michos EDet al. Dietary components and risk of cardiovascular disease and all-cause mortality: a review of evidence from meta-analyses. Eur J Prev Cardiol 2019; 26: 1415–1429. DOI: 10.1177/2047487319843667
Google Scholar | SAGE Journals | ISI15. Wang, X, Liu, F, Li, J, et al. Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: the China-PAR project. Eur J Prev Cardiol 2020; 27: 1956–1963.
Google Scholar16. Tverdal, A, Selmer, R, Cohen, JM, et al. Coffee consumption and mortality from cardiovascular diseases and total mortality: does the brewing method matter? Eur J Prev Cardiol 2020; 27: 1986–1993.
Google Scholar17. Baumeister, SE, Finger, JD, Gläser, S, et al. Alcohol consumption and cardiorespiratory fitness in five population-based studies. Eur J Prev Cardiol 2018; 25: 164–172.
Google Scholar | SAGE Journals | ISI18. Spiegelman D, Lovato LC, Khudyakov P, et al. The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk. Eur J Prev Cardiol 2020; 27: 1967–1982.
Google Scholar19. Scherrer, JF, Salas, J, Lustman, P, et al. Combined effect of posttraumatic stress disorder and prescription opioid use on risk of cardiovascular disease. Eur J Prev Cardiol 2020; 27: 1412–1422. DOI: 10.1177/204748731985071
Google Scholar | SAGE Journals20. Masoudkabir, F, Yavari, N, Pashang, M, et al. Effect of persistent opium consumption after surgery on the long-term outcomes of surgical revascularisation. Eur J Prev Cardiol 2020; 27: 1996–2003.
Google Scholar